APA (7th ed.) Citation

M, A., A, A., C, S., C, L., L, M., C, L., . . . RM, A. (2021). PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS. Acta oncologica (Stockholm, Sweden), 60(4), 531. https://doi.org/10.1080/0284186X.2021.1881161

Chicago Style (17th ed.) Citation

M, Abdulla, et al. "PD-L1 and IDO1 Are Potential Targets for Treatment in Patients with Primary Diffuse Large B-cell Lymphoma of the CNS." Acta Oncologica (Stockholm, Sweden) 60, no. 4 (2021): 531. https://doi.org/10.1080/0284186X.2021.1881161.

MLA (9th ed.) Citation

M, Abdulla, et al. "PD-L1 and IDO1 Are Potential Targets for Treatment in Patients with Primary Diffuse Large B-cell Lymphoma of the CNS." Acta Oncologica (Stockholm, Sweden), vol. 60, no. 4, 2021, p. 531, https://doi.org/10.1080/0284186X.2021.1881161.